Evidence of effectiveness and safety in combined therapies is scarce and based on case reports and small case series. We report a case of dual biologic therapy with ustekinumab and dupilumab in a patient with severe Crohn disease and atopic dermatitis. There was no interference between these drugs after a 7-month follow-up.
Keywords: atopic dermatitis; biologic treatment; combined therapies; dupilumab; monoclonal antibodies; ustekinumab.
© 2023 The Australasian College of Dermatologists.